Studies have shown that TLR4 signaling is activated during IBD pathogenesis, and the activated TLR4 signaling triggers innate NF-κB signaling and promotes pro-inflammatory cytokine production, contributing to colitis (5, 64). This evidence concerns the gene NFKB1 and inflammatory bowel disease.